Search research articles
Contact Us
Filters
Showing results (191-200 of 306) with videos related to
Page
of 31
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 18, 2011
Phase I study of oral azacitidine in myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia
Guillermo Garcia-Manero, Steven D Gore, Christopher Cogle, et al.
Cancer
|
September 5, 2019
Temporal patterns and predictors of receiving no active treatment among older patients with acute myeloid leukemia in the United States: A population-level analysis
Amer M Zeidan, Nikolai A Podoltsev, Xiaoyi Wang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 18, 2011
Role of allogeneic transplantation for FLT3/ITD acute myeloid leukemia: outcomes from 133 consecutive newly diagnosed patients from a single institution
Amy E DeZern, Anthony Sung, Sharon Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2007
Sequential flavopiridol, cytosine arabinoside, and mitoxantrone: a phase II trial in adults with poor-risk acute myelogenous leukemia
Judith E Karp, B Douglas Smith, Mark J Levis, et al.
Epigenetics
|
July 31, 2010
Epigenetic differences in cytogenetically normal versus abnormal acute myeloid leukemia
Elizabeth A Griffiths, Steven D Gore, Craig M Hooker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 1, 1996
A phase I and pharmacological study of topotecan infused over 30 minutes for five days in patients with refractory acute leukemia
E K Rowinsky, S H Kaufmann, S D Baker, et al.
Leukemia & Lymphoma
|
August 28, 2010
Acute myeloid leukemia is characterized by Wnt pathway inhibitor promoter hypermethylation
Elizabeth A Griffiths, Steven D Gore, Craig Hooker, et al.
Leukemia Research
|
March 28, 2002
Long-term follow-up of intensive ara-C-based chemotherapy followed by bone marrow transplantation for adult acute lymphoblastic leukemia: impact of induction Ara-C dose and post-remission therapy
E M Sotomayor, S Piantadosi, C B Miller, et al.
Blood
|
June 15, 2007
A phase 1 clinical-laboratory study of clofarabine followed by cyclophosphamide for adults with refractory acute leukemias
Judith E Karp, Rebecca M Ricklis, Kumudha Balakrishnan, et al.
Haematologica
|
April 16, 2013
A multivariate analysis of the relationship between response and survival among patients with higher-risk myelodysplastic syndromes treated within azacitidine or conventional care regimens in the randomized AZA-001 trial
Steven D Gore, Pierre Fenaux, Valeria Santini, et al.
Page
of 31
Search research articles
Search
Showing results (191-200 of 306) with videos related to
Sort By:
Page
of 31
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 18, 2011
Phase I study of oral azacitidine in myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia
Guillermo Garcia-Manero, Steven D Gore, Christopher Cogle, et al.
Cancer
|
September 5, 2019
Temporal patterns and predictors of receiving no active treatment among older patients with acute myeloid leukemia in the United States: A population-level analysis
Amer M Zeidan, Nikolai A Podoltsev, Xiaoyi Wang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 18, 2011
Role of allogeneic transplantation for FLT3/ITD acute myeloid leukemia: outcomes from 133 consecutive newly diagnosed patients from a single institution
Amy E DeZern, Anthony Sung, Sharon Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2007
Sequential flavopiridol, cytosine arabinoside, and mitoxantrone: a phase II trial in adults with poor-risk acute myelogenous leukemia
Judith E Karp, B Douglas Smith, Mark J Levis, et al.
Epigenetics
|
July 31, 2010
Epigenetic differences in cytogenetically normal versus abnormal acute myeloid leukemia
Elizabeth A Griffiths, Steven D Gore, Craig M Hooker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 1, 1996
A phase I and pharmacological study of topotecan infused over 30 minutes for five days in patients with refractory acute leukemia
E K Rowinsky, S H Kaufmann, S D Baker, et al.
Leukemia & Lymphoma
|
August 28, 2010
Acute myeloid leukemia is characterized by Wnt pathway inhibitor promoter hypermethylation
Elizabeth A Griffiths, Steven D Gore, Craig Hooker, et al.
Leukemia Research
|
March 28, 2002
Long-term follow-up of intensive ara-C-based chemotherapy followed by bone marrow transplantation for adult acute lymphoblastic leukemia: impact of induction Ara-C dose and post-remission therapy
E M Sotomayor, S Piantadosi, C B Miller, et al.
Blood
|
June 15, 2007
A phase 1 clinical-laboratory study of clofarabine followed by cyclophosphamide for adults with refractory acute leukemias
Judith E Karp, Rebecca M Ricklis, Kumudha Balakrishnan, et al.
Haematologica
|
April 16, 2013
A multivariate analysis of the relationship between response and survival among patients with higher-risk myelodysplastic syndromes treated within azacitidine or conventional care regimens in the randomized AZA-001 trial
Steven D Gore, Pierre Fenaux, Valeria Santini, et al.
Page
of 31